Antiplatelet drug

Antiplatelet Drugs

Various types of antiplatelet medications used in thrombotic disease prevention.

Antiplatelet Drugs, also known as platelet agglutination inhibitors or platelet aggregation inhibitors, are pharmaceuticals that reduce platelet aggregation and inhibit thrombus (blood clot) formation. They play a crucial role in the management and prevention of thrombotic cerebrovascular and cardiovascular diseases.

Mechanism of Action

Antiplatelet drugs work by interrupting the process of platelet aggregation, a key step in blood clot formation. Common mechanisms include:

• Inhibition of the enzyme cyclooxygenase (as in aspirin)
• Blocking P2Y12 adenosine diphosphate (ADP) receptors on platelets (as in clopidogrel)

Clinical Uses

Illustration of the cardiovascular system, where antiplatelet drugs are commonly used.

These drugs are widely used for:

• Primary prevention of heart attack and stroke in high-risk patients
• Secondary prevention of thrombotic events in patients with a history of cardiovascular diseases
• Patients undergoing certain surgical procedures, like angioplasty

Differences from Anticoagulants

While both antiplatelet drugs and anticoagulants prevent clot formation, they work in different ways. Anticoagulants, such as warfarin, act on the blood coagulation cascade, whereas antiplatelet drugs specifically target platelet aggregation processes. Antiplatelets are particularly effective in the arterial circulation, where anticoagulants have less effect.

External Links

• American Heart Association - Medications for Arrhythmia
• National Center for Biotechnology Information - Antiplatelet Medication

Antiplatelet drug Resources
Latest articles Most recent articles Ongoing trials	Wikipedia